These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 29408092)

  • 1. Topical application of Hydroxysafflor Yellow A accelerates the wound healing in streptozotocin induced T1DM rats.
    Gao SQ; Chang C; Niu XQ; Li LJ; Zhang Y; Gao JQ
    Eur J Pharmacol; 2018 Mar; 823():72-78. PubMed ID: 29408092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of deferoxamine and hydroxysafflor yellow A to accelerate diabetic wound healing via enhanced angiogenesis.
    Gao SQ; Chang C; Li JJ; Li Y; Niu XQ; Zhang DP; Li LJ; Gao JQ
    Drug Deliv; 2018 Nov; 25(1):1779-1789. PubMed ID: 30338719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of inhibition of the abnormal proliferation of human umbilical vein endothelial cells by hydroxysafflor-yellow A.
    Wang J; Wang J; Wang X; Liu L; Hu J; Yu X; Xu Y; Niu X; Lin Z; Zhang Y; Zhang X; Zhang Q
    Pharm Biol; 2016 Sep; 54(9):1800-7. PubMed ID: 26730646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxysafflor yellow A exerts anti-fibrotic and anti-angiogenic effects through miR-29a-3p/PDGFRB axis in liver fibrosis.
    Xue X; Li Y; Zhang S; Yao Y; Peng C; Li Y
    Phytomedicine; 2024 Sep; 132():155830. PubMed ID: 38959553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
    Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A
    PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hydroxysafflor yellow A on proliferation and collagen synthesis of rat vascular adventitial fibroblasts induced by angiotensin II.
    Yuan W; Yang D; Sun X; Liu W; Wang L; Li X; Man X; Fu Q
    Int J Clin Exp Pathol; 2014; 7(9):5772-81. PubMed ID: 25337218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolin mediated pro-angiogenic role of Hydroxysafflor Yellow A in ischaemic cardiac dysfunction: Post-transcriptional regulation of VEGF-A and MMP-9.
    Zou J; Wang N; Liu M; Bai Y; Wang H; Liu K; Zhang H; Xiao X; Wang K
    J Cell Mol Med; 2018 May; 22(5):2692-2705. PubMed ID: 29512890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin-induced angiogenesis hastens wound healing in diabetic rats.
    Kant V; Gopal A; Kumar D; Pathak NN; Ram M; Jangir BL; Tandan SK; Kumar D
    J Surg Res; 2015 Feb; 193(2):978-88. PubMed ID: 25454972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis.
    Zhang Y; Guo J; Dong H; Zhao X; Zhou L; Li X; Liu J; Niu Y
    Eur J Pharmacol; 2011 Jun; 660(2-3):438-44. PubMed ID: 21536026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arnebin-1 promotes the angiogenesis of human umbilical vein endothelial cells and accelerates the wound healing process in diabetic rats.
    Zeng Z; Zhu BH
    J Ethnopharmacol; 2014 Jul; 154(3):653-62. PubMed ID: 24794013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
    Pan R; Zhang Y; Zang B; Tan L; Jin M
    J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxysafflor Yellow A Promotes Angiogenesis via the Angiopoietin 1/ Tie-2 Signaling Pathway.
    Chen T; Chen N; Pang N; Xiao L; Li Y; Li R; Luo M; Deng X; Ren M; Wu J; Wang L
    J Vasc Res; 2016; 53(5-6):245-254. PubMed ID: 27894114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
    Jin M; Wang L; Wu Y; Zang BX; Tan L
    Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical application of substance P promotes wound healing in streptozotocin-induced diabetic rats.
    Kant V; Kumar D; Kumar D; Prasad R; Gopal A; Pathak NN; Kumar P; Tandan SK
    Cytokine; 2015 May; 73(1):144-55. PubMed ID: 25748837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of hydroxysafflor yellow A (HSYA) on alcohol-induced liver injury in rats.
    He Y; Liu Q; Li Y; Yang X; Wang W; Li T; Zhang W; Cui Y; Wang C; Lin R
    J Physiol Biochem; 2015 Mar; 71(1):69-78. PubMed ID: 25626885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1/VEGF-A/SDF-1α cascade.
    Wei G; Yin Y; Duan J; Guo C; Zhu Y; Wang Y; Xi M; Wen A
    Biomed Pharmacother; 2017 Apr; 88():409-420. PubMed ID: 28122306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of hydroxysafflor yellow A on PDGF‑BB‑induced proliferation and migration of vascular smooth muscle cells via mediating Akt signaling.
    Song Y; Long L; Zhang N; Liu Y
    Mol Med Rep; 2014 Sep; 10(3):1555-60. PubMed ID: 24939805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis.
    McLaughlin PJ; Immonen JA; Zagon IS
    Exp Biol Med (Maywood); 2013 Jul; 238(7):733-43. PubMed ID: 23788174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α.
    Hou Z; Nie C; Si Z; Ma Y
    Diabetes Res Clin Pract; 2013 Jul; 101(1):62-71. PubMed ID: 23726275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of the HIF-1α-VEGFA-Notch1 signaling pathway by Hydroxysafflor yellow A promotes angiogenesis and reduces myocardial ischemia-reperfusion injury.
    Ge C; Meng D; Peng Y; Huang P; Wang N; Zhou X; Chang D
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113097. PubMed ID: 39260311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.